STOUGHTON, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the appointment of Richard Malamut, M.D., as the company’s first Chief Medical Officer, effective April 1, 2019. In this newly created role, Dr. Malamut will lead Collegium’s Clinical, Medical Affairs, Regulatory and Scientific Affairs functions.
“We are excited to have Rick join the Collegium leadership team. He brings with him more than 25 years of experience across all stages of product development, as well as clinical and operational expertise,” said Joe Ciaffoni, Chief Executive Officer of Collegium. “We look forward to his contributions, as we leverage his extensive background in the field of pain medicine to deliver on our commitment to become the leader in responsible pain management.”
Most recently, Dr. Malamut served as Chief Medical Officer, Head of Research and Development and Senior Vice President for Braeburn Pharmaceuticals, Inc. Prior to that, Dr. Malamut was Chief Medical Officer at Avanir Pharmaceuticals and was Senior Vice President of Global Clinical Development at Teva Pharmaceutical Industries Ltd., where he was responsible for Pain, Neuropsychiatry and repurposing and reformulation of existing molecules. His experience also includes roles of increasing responsibility at Bristol-Myers Squibb and AstraZeneca.
Dr. Malamut earned his medical degree from Hahnemann University in Philadelphia and completed both a residency in neurology and a fellowship in neuromuscular disease. He worked as a board-certified academic and clinical neurologist for 17 years and has more than 50 publications in the fields of pain medicine, neuromuscular disease, autonomic disease and neurodegenerative disease.
“My experience in developing medicines for pain management equip me with a unique perspective to apply to the advancement and expansion of Collegium’s pain portfolio,” said Dr. Malamut. “I am thrilled to be joining a company with a deep commitment to offering differentiated and innovative treatment options for people suffering from pain and look forward to contributing to the success of Collegium.”
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.
